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Oral immunotherapy has had limited success in es-
tablishing tolerance in food allergy, reflecting failure
to elicit an effective regulatory T (Treg) cell response.
We show that disease-susceptible (Il4raF709) mice
with enhanced interleukin-4 receptor (IL-4R) signaling
exhibited STAT6-dependent impaired generation
and function of mucosal allergen-specific Treg cells.
This failure was associated with the acquisition by
Treg cells of a T helper 2 (Th2)-cell-like phenotype,
also found in peripheral-blood allergen-specific Treg
cells of food-allergic children. Selective augmen-
tation of IL-4R signaling in Treg cells induced their
reprogramming into Th2-like cells and disease sus-
ceptibility, whereas Treg-cell-lineage-specific dele-
tion of Il4 and Il13 was protective. IL-4R signaling
impaired the capacity of Treg cells to suppress mast
cell activation and expansion, which in turn drove
Th2 cell reprogramming of Treg cells. Interruption of
Th2 cell reprogramming of Treg cells might thus pro-
vide candidate therapeutic strategies in food allergy.
INTRODUCTION
Food allergy is a major health problem in developed countries,
where the prevalence reaches up to 6% in children and 3% in
the adult population (Sicherer, 2011). Up to half of food-allergic
subjects are sensitized tomultiple foods, reflecting a generalized
and fundamental breakdown in oral tolerance to foods (Liu et al.,
2010; Sicherer, 2011). Oral immunotherapy (OIT) has had limited
success in conferring long-term tolerance in food-allergic sub-
jects (Jones et al., 2014). Long-term tolerance, defined as per-
sistent tolerance to the allergenic food for at least 6 months after
withdrawal of maintenance OIT, has been achieved in only 13%–
28% of treated subjects (Moran et al., 2013; Sicherer, 2011).
Hence, understanding how oral tolerance is subverted in food
allergy is of critical importance in elucidating disease pathogen-
esis and in the design of rational therapeutic and preventive
measures.512 Immunity 42, 512–523, March 17, 2015 ª2015 Elsevier Inc.Oral tolerance to foods is an active immunological process
that involves allergen-specific regulatory T (Treg) cells (Berin
and Mayer, 2013; Liu et al., 2010; Sicherer, 2011). Genetic and
immunological evidence supports a pivotal role for Treg cells in
enforcing oral tolerance to foods (Chatila et al., 2000; Jones
et al., 2014; Torgerson et al., 2007). In children who outgrow
food allergy, tolerance is associated with the development of
allergen-specific Treg cells (Karlsson et al., 2004).
Oral tolerance is dependent on the development of induced
Treg (iTreg) cells from naive conventional CD4+ T cells (CD4+
Tconv) upon their activation in the presence of TGF-b1 and
CD103+ dendritic cells (DCs) in the gut (Apostolou and von
Boehmer, 2004; Haribhai et al., 2009; Mucida et al., 2005). iTreg
cells regulate T helper 2 (Th2) cell responses at the mucosal sur-
faces (Curotto de Lafaille et al., 2008; Josefowicz et al., 2012).
They are less stable and more plastic than thymic-derived natu-
ral Treg (nTreg) cells (Bilate and Lafaille, 2012; Schmitt et al.,
2012). This plasticity is reflected at the epigenetic level: whereas
the Foxp3 locus is stably hypomethylated in nTreg cells, it is
weakly so in iTreg cells (Floess et al., 2007; Schmitt et al., 2012).
Notwithstanding the genetic and functional data linking
Foxp3+ Treg cells to food allergy, the role of these cells in disease
pathogenesis remains associative. In this report, we have made
use of a murine model involving a gain-of-function IL-4Ra chain
allele (Il4raF709) to dissect the role of Treg cells in food allergy
(Burton et al., 2014; Mathias et al., 2011; Noval Rivas et al.,
2013; Tachdjian et al., 2010). Our results reveal deficient forma-
tion and impaired function of allergen-specific Treg cells in food
allergy, the latter of which is a consequence of their Th2 cell re-
programming. Together, these deficits promote disease by dis-
rupting a Treg-mast cell regulatory loop.RESULTS
Deficiency of Allergen-Specific Treg Cells in
Food-Allergic Il4raF709 Mice
The interleukin-4 (IL-4) receptor (IL-4R) pathway has been impli-
cated in pathogenesis of human food allergy. Increased allergen-
induced IL-4 production has been associated with clinically
active food allergy, and its decline coincides with the emer-
gence of oral tolerance (Sicherer et al., 2010, 2014). Both
IL4RA and STAT6 polymorphisms have been associated with
Figure 1. Deficiency of Allergen-Specific Treg Cells in OVA-Allergic Il4raF709 Mice
(A) Changes in core body temperature in PBS- or OVA-SEB-sensitized WT and Il4raF709 mice after oral OVA challenge.
(B and C) Total and OVA-specific serum IgE concentrations (B), intestinal mast cell number per low-power field (LPF), and serum MMCP-1 concentrations after
anaphylaxis (C) in the mouse groups shown in (A).
(D) Flow cytometric analysis and enumeration of CD4+IL-4+ and CD4+IFN-g+ T cells in the MLNs of PBS- or OVA-SEB-sensitized WT and Il4raF709 mice.
(E and F) Frequency (E) and numbers (F) of CD4+Foxp3+ Treg cells in different tissues of PBS-, SEB-, and OVA-SEB-sensitized WT and Il4raF709 mice.
(G) Foxp3 mRNA in the SI, MLNs, and spleens of PBS- or OVA-SEB-sensitized WT and Il4raF709 mice.
(H) Flow cytometric analysis of CD4+Foxp3+ Treg cell frequencies in cultures of MLN cells isolated from OVA-SEB-sensitized WT and Il4raF709 mice and stim-
ulated with OVA323–339 peptide-pulsed DCs.
(I) Frequencies of proliferating cells in gated CD4+Foxp3+ Treg cells shown in (H) and identified by proliferative dye (CellTrace Violet) dilution.
Results are representative of three independent experiments. n = 5–10 mice/group. *p < 0.05, **p < 0.01, and ***p < 0.001 by Student’s unpaired two-tailed t test
and two-way ANOVA with post-test analysis.food-allergen-specific immunoglobulin E (IgE) responses (Amoli
et al., 2002; Brown et al., 2012). Accordingly, in our studies we
employed mice carrying a IL-4Ra chain mutation (Il4raF709) that
inactivates the receptor’s immunotyrosine inhibitory motif
(ITIM) and thusmakes themice particularly prone to the develop-
ment of oral allergic sensitization (Burton et al., 2014; Mathias
et al., 2011; Noval Rivas et al., 2013; Tachdjian et al., 2010).
Oral sensitization of Il4raF709, but not wild-type (WT), mice with
ovalbumin (OVA) in combination with the adjuvant staphylo-
coccal enterotoxin B (SEB) rendered them susceptible to robustanaphylaxis upon oral challenge with OVA. The food-allergic
responsemanifested as amarked drop in core body temperature
upon OVA challenge, increased total and OVA-specific IgE, mast
cell expansion and release of the mast cell granule protease 1
(MMCP-1), and intense Th2 cell skewing (Figures 1A–1D). Oral
administration of SEB alone has no effect on the parameters of
the anaphylactic response (Ganeshan et al., 2009). The differen-
tial susceptibility of Il4raF709 mice to oral sensitization and
anaphylaxis was maintained when WT and Il4raF709 littermates
were analyzed, indicating that it was primarily genotype drivenImmunity 42, 512–523, March 17, 2015 ª2015 Elsevier Inc. 513
(Noval Rivas et al., 2013, and data not shown). The frequencies
and numbers of Foxp3+ Treg cells in the spleens, mesenteric
lymph nodes (MLNs), and lamina propria of the small intestine
(SI) were lower in OVA-SEB-sensitized Il4raF709 mice than in
WT control mice. This was especially so in the SI, where Treg
cells were lower even in PBS- or SEB-treated Il4raF709 mice
than in WT mice (Figures 1E and 1F). Furthermore, whereas
Foxp3 mRNA expression in splenic tissues of PBS- and OVA-
SEB-sensitized WT and Il4raF709 mice was similar, it was signifi-
cantly lower in the SI and the MLNs of Il4raF709 mice (Figure 1G).
Further analysis revealed that the Il4raF709 mice were particularly
lacking in allergen-specific Treg cells. Incubation of MLN cells of
OVA-SEB-sensitized mice with OVA323–338 peptide-pulsed DCs
resulted in higher proliferation of WT than of Il4raF709 Foxp3+
Treg cells (Figures 1H and 1I). These results reveal the presence
of a deficient Treg cell response in food-allergic Il4raF709 mice.
Impaired iTreg Cell Formation in Food-Allergic
Il4raF709 Mice
Treg cells isolated from PBS- and OVA-SEB-sensitized WT and
Il4raF709 mice had similar profiles of key canonical markers, in-
cluding Foxp3, CD25, and CTLA-4. Expression of ICOS and Heli-
os was markedly increased in Treg cells of OVA-SEB-sensitized
Il4raF709 mice, consistent with a heightened activation profile (Fig-
ure S1A; Smigiel et al., 2014; Thornton et al., 2010). The samecells
showed evidence of decreased proliferation, as revealed by Ki67
staining (Figures S1B and S1C). The Treg cell proliferative defect
was further characterized with neuropillin-1 (Nrp1) as a marker
to discriminate between nTreg and iTreg cells (Weiss et al.,
2012). Results revealed that the decreased Treg cell proliferation
in sensitized Il4raF709mice affected the Nrp1lo Treg cell population
(reflective of iTreg cells), but not theNrp1hi population (reflective of
nTreg cells) (Figures S1D and S1E). The proliferative defect was
compounded by increased Treg cell apoptosis, as detected
by annexin V staining (Figures S1F and S1G). Analysis of the
conserved non-coding region 2 (CNS2) of Foxp3 for epigenetic
demethylation, which is normally more pronounced in nTreg cells,
revealed its increase inmesenteric Tregcells of sensitized Il4raF709
mice, consistent with a selective decrease in iTreg cells (Figures
S1H and S1I; Floess et al., 2007; Haribhai et al., 2011; Schmitt
et al., 2012). The apparent decrease in iTreg cells in allergen-
sensitized Il4raF709 mice could not be ascribed to deficiency of
factors critical for their generation in the SI, including TGF-b1
and the enzyme retinaldehydedehydrogenase 2 (RALDH-2), given
that transcripts encoding both proteins were higher in the SI of
sensitized Il4raF709mice than in the SI of control mice (Figure S1J).
We hypothesized that decreased allergen-specific Treg cell
responses in Il4raF709 mice reflected IL-4-signaling-mediated
suppression of iTreg cell formation (Dardalhon et al., 2008; Veld-
hoen et al., 2008). Consistent with this hypothesis, in vitro differ-
entiation of naive CD4+CD62LhiIl4raF709 T cells into iTreg cells
was more sensitive to IL-4 inhibition than that of WT cells (Fig-
ures 2A and 2B). The ability of IL-4 to disrupt naive CD4+Il4raF709
T cell differentiation into iTreg cells was abrogated in Il4raF709
Stat6–/– double-mutant T cells, indicating its STAT6 dependency
(Figures 2A and 2B). IL-4 inhibition of Il4raF709 iTreg cell differen-
tiation was not a dilutional artifact of excessive CD4+Foxp3–
T cell proliferation, as evidenced by enumeration of the respec-
tive cell population (Figure 2C).514 Immunity 42, 512–523, March 17, 2015 ª2015 Elsevier Inc.Impaired allergen-specific iTreg cell formation in Il4raF709 mice
was also observed in vivo with the use of transgenic DO11.10+
Rag2–/–Foxp3EGFPmice,which express theDO11.10 TCRspecific
to OVA323–339 peptide on a RAG2-deficient genetic background.
These mice normally carry naive DO11.10+CD4+Foxp3–, but not
Foxp3+, T cells. When fed OVA, they developed OVA-specific
iTreg cells expressing EGFP under control of Foxp3 (Figures
S2A–S2C), and mice with the Il4raF709 allele developed only
one-third as many DO11.10+ iTreg cells as did mice with the WT
Il4ra allele (Figures S2B and S2C). The Il4raF709DO11.10+ iTreg
cells had increased expression of IL-4 and the Th2 cell transcrip-
tion factors GATA-3 and IRF-4 and decreased IFN-g, consistent
with a skewed Th2-cell-like phenotype (Figures S2D–S2F).
Impaired allergen-specific iTreg cell formation in Il4raF709 mice
was further demonstrated in vivo in the context of an immuno-
competent host. Naive OVA-specific CD4+DO11.10+ Tconv cells
derived from either WT or Il4raF709 DO11.10+Rag2–/–Foxp3EGFP
mice were loaded with a proliferation dye and transferred
into OVA-SEB-sensitized Il4raF709 mice. After cell transfer, the
recipient mice were further sensitized with OVA-SEB and then
analyzed for susceptibility to anaphylaxis and for the presence
of DO11.10+EGFP+ iTreg cells and DO11.10+EGFP– effector
T cells in their MLNs (Figure 2E). OVA-SEB-sensitized Il4raF709
mice that received WT DO11.10+CD4+ Tconv cells were
protected from anaphylaxis, whereas those that received
Il4raF709DO11.10+CD4+ T cells were not (Figures 2F and 2G).
Compared to WT DO11.10+CD4+ T cells, transferred Il4raF709
DO11.10+CD4+ T cells were markedly less efficient in converting
into EGFP+ iTreg cells, and those that converted proliferated less
(Figures 2H–2J). All together, these results establish that iTreg
cell induction is impaired in food-allergic Il4raF709 mice.
Defective Function of Il4raF709 TregCells in Suppressing
Food Allergy
To establish whether allergen-specific Il4raF709 iTreg cells
are functionally competent, we determined the capacity of
OVA-specific iTreg cells to reverse established food allergy in
OVA-SEB-sensitized Il4raF709 mice. WT or Il4raF709 DO11.10+
Foxp3EGFP iTreg cells were differentiated in vitro from naive
CD4+ T cells, further purified by cell sorting on the basis of their
Foxp3EGFP expression, and given intravenously (2.5 3 106 cells/
mouse) to sensitized Il4raF709 mice (Figure S3A). The recipient
mice were further sensitized for 4 additional weeks and
then orally challenged. Administration of a single dose of WT
DO11.10+ iTreg cells suppressed the anaphylactic response of
sensitized Il4raF709 mice challenged with OVA (Figure 3A). This
suppression was associated with inhibition of total and OVA-
specific IgE responses as well as mast cell expansion and acti-
vation, indicative of disease remission (Figure 3B). They also
suppressed Th2 cell cytokine expression, including that of Il4,
Il13, and Il9, in the gut (Figure S3B). In contrast, Il4raF709
DO11.10+Foxp3EGFP iTreg cells failed to suppress anaphylaxis
or to inhibit the aforementioned disease parameters (Figures
3A and 3B). They also failed to suppress Th2 cell cytokine
expression in the SI of OVA-SEB-sensitized Il4raF709 mice.
Transferred WT and Il4raF709 DO11.10+Foxp3EGFP iTreg cells
were retrieved at similar numbers in the spleens and MLNs of
recipient mice, confirming that the Il4raF709 iTreg cells were func-
tionally defective in suppressing disease (Figures S3C and S3D).
Figure 2. Impaired Allergen-Specific iTreg Cell Formation in OVA-Allergic Il4raF709 Mice
(A) TGF-b induction of iTreg cells from naive CD4+ T cells isolated from WT, Il4raF709, Stat6–/–, and Il4raF709Stat6–/– mice in the absence or presence of IL-4
(10 ng/ml).
(B) Effect of different IL-4 concentrations on TGF-b induction of iTreg cells from naive T cells of the groups shown in (A).
(C) Absolute numbers of proliferating WT and Il4raF709 CD4+Foxp3+ iTreg cells and CD4+Foxp3– effector cells.
(D) Schema of the experimental design of in vivo iTreg cell induction studies. Naive DO11.10+CD4+ Tconv cells from WT or Il4raF709 DO11.10+Rag2–/–Foxp3EGFP
mice were loaded with CellTrace Violet dye and injected into OVA-SEB-sensitized Il4raF709 recipients.
(E) Change in core body temperature after OVA challenge.
(F) Total and OVA-specific serum IgE concentrations and MMCP-1 release after anaphylaxis.
(G) Flow cytometric analysis of iTreg cell conversion of adoptively transferred DO11.10+CD4+ Tconv cells in the MLNs of recipient OVA-SEB-sensitized Il4raF709
mice.
(H) Percentages of donor CD4+Foxp3EGFP+ cells (left panel) and CD4+Foxp3EGFP– cells (right panel) in the MLNs of the recipient mice in (G).
(I) Frequencies of proliferating cells in gated CD4+Foxp3EGFP+ cells (left panel) and CD4+Foxp3EGFP– cells (right panel) from (G).
Results are representative of three independent experiments. n = 5–10 mice/group. *p < 0.05, **p < 0.01, and ***p < 0.001 by Student’s unpaired two-tailed t test
and two-way ANOVA with post-test analysis.To determine whether defective suppression of oral allergic
sensitization was also an attribute of in-vivo-derived allergen-
specific Il4raF709 Treg cells, we employed isolated DO11.10+
Treg cells from RAG-sufficient WT and Il4raF709 DO11.10+
Foxp3EGFP mice in a Treg cell transfer model of enforced toler-
ance (Noval Rivas et al., 2013). WT, but not Il4raF709, DO11.10+
Foxp3EGFP Treg cells were found effective in preventing OVA-
induced sensitization and anaphylaxis in Il4raF709 mice (Figures
3C and 3D). To determine whether Treg cell dysfunction in
Il4raF709 mice resulted from excessive IL-4R-STAT6 signaling,
we examined the capacity of Treg cells derived fromSTAT6-defi-
cient WT and Il4raF709 DO11.10+Foxp3EGFP mice to suppress
food allergy in sensitized Il4raF709 mice. Unlike STAT6-sufficient
Il4raF709 Treg cells, STAT6-deficient Il4raF709 Treg cells wereequivalent to their WT counterparts in suppressing sensitization
and anaphylaxis (Figures 3C and 3D). All transferred DO11.10+
Treg cell populations were retrieved at similar frequencies
and numbers in recipient mice, indicating that the failure of
Il4raF709DO11.10+Foxp3EGFP Treg cells to suppress food allergy
reflects an intrinsic functional defect (Figures S3E and S3F).
We further explored the role of STAT6 signaling in disrupting
Il4raF709 Treg cell function by using an in vitro suppression assay
of IgE-dependent mast cell activation by Treg cells. Treatment of
IgE-anti-DNP-sensitized mast cells with DNP-BSA resulted in
mast cell activation and degranulation, marked by the increased
surface expression of the granule marker LAMP-1 (CD107a)
(Burton et al., 2013, 2014; Gru¨tzkau et al., 2004; Leonard et al.,
2012). The addition of WT iTreg cells suppressed LAMP-1Immunity 42, 512–523, March 17, 2015 ª2015 Elsevier Inc. 515
Figure 3. OVA-Specific Il4raF709 Treg Cells Fail to Suppress Food Allergy
(A) Changes in core body temperature after OVA challenge of OVA-SEB-sensitized Il4raF709 mice that had received in-vitro-generated WT or Il4raF709
DO11.10+Foxp3EGFP iTreg cells, as described in Figure S3A.
(B) Total and OVA-specific serum IgE concentrations, MMCP-1 release, and SI mast cell counts in the mouse groups shown in (A).
(C) Changes in core body temperature after OVA challenge of OVA-SEB-sensitized Il4raF709 mice that were either left untreated or given either WT DO11.10+
Foxp3EGFP+ Treg cells or Il4raF709DO11.10+Foxp3EGFP+ STAT6-sufficient or deficient Treg cells.
(D) Total and OVA-specific serum IgE and serumMMCP-1 concentrations after anaphylaxis of the mouse groups from (C). n = 5–17 mice/group pooled from two
different experiments. *p < 0.05, **p < 0.01, and ***p < 0.001 by one- and two-way ANOVA with post-test analysis.expression upon mast cell exposure to antigen (Figure S4).
Suppression by Il4raF709, but not WT, iTreg cells was sensitive
to IL-4 addition, resulting in ineffective inhibition of LAMP-1
expression. Concurrent STAT6 deficiency corrected the deficit
in Il4raF709 iTreg cell suppression of mast activation, as evi-
denced by decreased LAMP-1 expression on activated mast
cells (Figure S4). These findings confirm that Il4raF709 Treg cells
are functionally impaired in suppressing mast cell activation as a
result of excessive STAT6 signaling.
Th2 Cell Reprogramming of Treg Cells Is Critical to Oral
Allergic Sensitization
Consistent with the pivotal role of STAT6 in incapacitating oral-
tolerance induction by Il4raF709 Treg cells, a substantial fraction
of Treg cells in OVA-SEB Il4raF709 mice underwent reprogram-
ming into Th2-like cells. MLN Treg cells of OVA-SEB-sensitized
Il4raF709, but not WT, mice manifested increased expression of
IL-4, all the while maintaining their Foxp3 expression (Figures
4A and 4B). To determine whether the Th2-like Treg cells were
a transitional population in the process of generating Foxp3–
Th2 cells (ex-Treg cells), we employed a lineage-tracing ap-
proach by using a Rosa26 stop-flox YFP reporter (R26YFP/YFP)
crossed with a Foxp3-directed Cre recombinase (Foxp3EGFPCre)
on WT and Il4raF709 backgrounds. Sensitization of Il4raF709
Foxp3EGFPCreR26YFP/YFP mice, but not Foxp3EGFPCreR26YFP/YFP
mice, with OVA-SEB rendered them susceptible to robust
anaphylaxis upon oral challenge with OVA (data not shown).
IL-4 expression by Treg cells (EGFP+YFP+), ex-Treg cells
(EGFP–YFP+), and CD4+ Tconv cells (EGFP–YFP–) was examined516 Immunity 42, 512–523, March 17, 2015 ª2015 Elsevier Inc.by flow cytometry. Compared to similarly treated WT mice,
sensitized Il4raF709 mice manifested a modest increase in the
number of ex-Treg cells (Figures 4C and 4D). However, those
ex-Treg cells did not secrete IL-4, indicating that Th2-like Treg
cells did not contribute to the generation of Tconv Th2 cells.
These results also indicate that Th2-like Treg cells are unlikely
to emerge from activated Tconv Th2 cells with transient Foxp3
expression, given that such a process would also lead to the
accumulation of IL-4+EGFP–YFP+ cells (Figure 4E).
Further characterization of the Th2-like Treg cells in Il4raF709
mice showed that expression of the pro-Th2 cell transcription
factor GATA-3 was dramatically higher in a fraction of ex-vivo-
isolated Il4raF709 Treg cells, both at baseline and especially after
OVA sensitization, than in WT Treg cells (Figures 4F and 4G).
The pro-Th2 cell factor IRF4 was also more highly expressed in
Il4raF709 Treg cells (Figures 4F and 4G). To determine the contri-
bution of Th2 cell cytokine production by reprogrammed Treg
cells to the food-allergic response, we employed Il4raF709 mice
with targeted deletion of both Il4 and Il13 in Treg cells by using
a floxed Il4-Il13 gene cassette and a Foxp3-directed Cre re-
combinase (Il4raF709Foxp3EGFPCreIl4-Il13D/D mice) (Figure 5A).
Results revealed that compared to Il4raF709Foxp3EGFPCre control
mice, OVA-SEB-sensitized Il4raF709Foxp3EGFPCreIl4-Il13D/Dmice
were protected against anaphylaxis after OVA challenge (Figures
5B and 5C). Furthermore, Foxp3-directed deletion of Il4 and
Il13 corrected the deficit in CD4+Foxp3+ Treg cells in sensitized
Il4raF709 mice and reversed their Th2 cell reprogramming, as as-
sessed by GATA-3 and IRF-4 expression (Figures 5D and 5E). It
also reduced IL-4 production by Tconv Th2 cells (Figure 5F).
Figure 4. Treg Cells of Food-Allergic Il4raF709 Mice Undergo Pathogenic Th2-Cell-like Reprogramming
(A) IL-4 expression by MLN CD4+Foxp3+ Treg cells from OVA-SEB-sensitized WT and Il4raF709 mice.
(B) Frequencies (upper panel) and absolute numbers (bottom panel) of IL-4-expressing CD4+Foxp3+ Treg cells isolated from the MLNs of PBS- and OVA-SEB-
sensitized WT and Il4raF709 mice.
(C) Flow cytometric analysis of EGFP and YFP expression in CD4+ T cells isolated from the MLNs of OVA-SEB-sensitized Foxp3EGFPCreR26YFP/YFP and
Il4raF709Foxp3EGFPCreR26YFP/YFP mice.
(D) Percentages (top panel) and numbers of Treg cells (EGFP+YFP+) and ex-Treg cells (EGFP–YFP+) in the MLNs of the mouse groups described in (C).
(E) Numbers of IL-4-secreting Tconv (EGFP–YFP–), ex-Treg (EGFP–YFP+), and Treg (EGFP+YFP+) CD4+ cells isolated from the MLNs of OVA-SEB-sensitized
Foxp3EGFPCreR26YFP/YFP and Il4raF709Foxp3EGFPCreR26YFP/YFP mice.
(F–H) Flow cytometric analysis (F), frequencies (G), and numbers (H) of GATA-3+ or IRF-4+ Treg cells isolated from theMLNs of PBS- andOVA-SEB-sensitizedWT
and Il4raF709 mice.
Results are representative of two to three independent experiments. n = 3–10mice/group. *p < 0.05, **p < 0.01, and ***p < 0.001 by one- and two-way ANOVAwith
post-test analysis and Student’s unpaired two-tailed t test.Collectively, these results indicate that Il4raF709 Treg cells are
reprogrammed to Th2-like cells after oral allergic sensitization
and contribute to disease pathogenesis through Th2 cell cyto-
kine expression.
IL-4 production by activated mast cells is critical in directing
the Th2 cell response in food allergy (Figures S5A and S5B;
Burton et al., 2014). Consistent with this observation, a key
mechanism driving Th2 cell reprogramming of Il4raF709 Treg
cells involved IgE-dependent mast cell expansion and acti-
vation. OVA-SEB-sensitized Il4raF709Fcer1a–/– double-mutant
mice, which lack the alpha chain of the high-affinity receptor
for IgE (FcεRIa), were completely protected from anaphylaxis
after oral OVA challenge, consistent with IgE and mast cell
dependence of the anaphylactic response (Figure S5C). Sig-
nificantly, FcεRIa deficiency profoundly impaired total and
OVA-specific IgE antibody responses and suppressed mast
cell expansion and activation (Figures S5D and S5E). Concur-
rent FcεRIa deficiency completely corrected the deficit in
CD4+Foxp3+ Treg cells and reversed Th2 cell reprogrammingof Treg cells in OVA-SEB-sensitized Il4raF709 mice, indica-
ting an essential role for dysregulated IgE-FcεRIa signaling
in amplifying the Th2 cell response and inducing Th2 cell
reprogramming of Treg cells in these mice (Figures S5F
and S5G).
Allergen-Specific Treg Cells of Human Subjects
with Food Allergy Exhibit Th2 Cell Reprogramming
We examined children with food allergy for evidence of Th2 cell
reprogramming of their Treg cells (Table S1). Compared to
peripheral-blood Treg cells of control subjects, those of food-
allergic children were decreased in numbers and had increased
expression of GATA-3 and IRF-4 (Figures 6A–6D). We also
examined Th2 cell cytokine expression in milk-specific Treg
cells of food-allergic and control subjects by identifying
their proliferation to milk allergens in in vitro cultures of freshly
isolated peripheral-blood mononuclear cells (PBMCs) (Fig-
ure S6A). CD4+Foxp3+ and CD4+Foxp3– cells of milk-allergic
children, but not those of healthy control subjects or of subjectsImmunity 42, 512–523, March 17, 2015 ª2015 Elsevier Inc. 517
Figure 5. Th2 Cell Cytokine Production by Th2-Cell-Reprogrammed
Treg Cells Is Critical to the Food-Allergic Response
(A) Real-time PCR analysis of Il4 mRNA transcripts in Tconv cells (CD4+
Foxp3–) and Treg cells (CD4+Foxp3+) sorted from the spleens of Il4raF709 and
Il4raF709Foxp3EGFPCreIl4-Il13D/D mice.
(B) Changes in core body temperature after OVA challenge of OVA-SEB-
sensitized Il4raF709 and Il4raF709Foxp3EGFPCreIl4-Il13D/D mice.
(C) Serum total IgE, OVA-specific IgE, and MMCP-1 concentrations after
anaphylaxis of the mice in (B).
(D) Percentages and numbers of CD4+Foxp3+ Treg cells in the MLNs of OVA-
SEB-sensitized Il4raF709 and Il4raF709Foxp3EGFPCreIl4-Il13D/D mice.
(E) Frequencies of GATA-3+ or IRF-4+ Treg cells isolated from the MLNs of
OVA-SEB-sensitized Il4raF709 and Il4raF709Foxp3EGFPCreIl4-Il13/ mice.
(F) Percentages (top panel) and numbers (bottom panel) of IL-4-producing
CD4+ Tconv cells in the MLNs of OVA-SEB-sensitized Il4raF709 and Il4raF709
Foxp3EGFPCreIl4-Il13D/D mice.
Results are representative of two independent experiments. n = 3–18 mice/
group. *p < 0.05, **p < 0.01, and ***p < 0.001 by one- and two-way ANOVAwith
post-test analysis and Student’s unpaired two-tailed t test.allergic to foods other than milk, proliferated in response
to milk-allergen stimulation (Figures S6B–S6E). Furthermore,
milk-allergic subjects exhibited increased frequencies of milk-
specific Treg cells that expressed IL-4 upon allergen stimula-
tion (Figures 6E and 6F). The same pattern was also observed
in the CD4+Foxp3– T cell compartment (Figures 6G and 6H).
Hence, Treg cells of human food-allergic subjects underwent
Th2 cell reprogramming similar to that of Il4raF709 food-allergic
mice.518 Immunity 42, 512–523, March 17, 2015 ª2015 Elsevier Inc.Rescue of Treg Cell Deficiency with Il4raF709CD4+
T Cells Confers Susceptibility to Food Allergy
To demonstrate that Il4raF709 Treg cells confer susceptibility to
food allergy, we reconstituted Thy1.2+Foxp3K276X newborn
pups, which lack functional Treg cells because of a nonsense
mutation in Foxp3, with CD4+ T cells from either WT Thy1.1+
mice or Thy1.1+Il4raF709Foxp3EGFP mice (as a source of nTreg
cells and Tconv cell precursors of iTreg cells) (Haribhai et al.,
2011). Rescued Foxp3K276X mice grew into adulthood and
harbored similar frequencies of grafted donor WT and Il4raF709
Thy1.1+Treg cells, whereas their CD4+ Tconv cells remained
overwhelmingly (R97%) of recipient host origin (Thy1.2+) (Fig-
ure 7A). In contrast, donor Thy1.1+CD4+ T cells injected into
WT Thy1.2+ newborn recipients failed to engraft (Figure 7B). At
7 weeks, the rescued Foxp3K276X mice were sensitized with
sham or OVA-SEB and then challenged with OVA. Only the
OVA-SEB-sensitized Foxp3K276X mice rescued with Thy1.1+
Il4raF709Foxp3EGFP cells underwent anaphylaxis (Figure 7C).
Mice rescued with Il4raF709CD4+ T cells exhibited increased
OVA-specific IgE responses and dysregulated mast cell ex-
pansion and activation (Figure 7D). Compared to WT Treg cells,
Il4raF709 Treg cells exhibited increased expression of IL-4 and
IL-13 (to a lesser extent), but not of IFN-g, after OVA sensitization
(Figure 7E). Thus, disease susceptibility was imparted by the
rescue of Foxp3K276X mice with donor Il4raF709 Treg cell lineage.
Treg-Cell-Specific Deletion of Ptpn6 Confers a
Th2-Cell-like Phenotype and Promotes Food Allergy
The Il4raF709mutationdisrupts the interaction between IL4-Ra and
the phosphotyrosine phosphatase Shp1 (Tachdjian et al., 2010).
Consistent with the critical function of Shp1 in regulating Th2 cell
responses, lineage-specific deletion of Ptpn6 (encoding Shp1) in
CD4+T cells enhanced IL-4R signaling and inducedTh2 cell skew-
ing (Johnson et al., 2013). We generated transgenic mice in which
Ptpn6wasspecifically deleted inTregcells byusingafloxedPtpn6
allele and Foxp3EGFPCre, both on a C57BL/6 background (Fig-
ure S7A). Ptpn6 transcripts were profoundly reduced (>95%) in
Treg, but not Tconv, cells of Foxp3EGFPCrePtpn6D/D mice (Fig-
ure S7B). The mice had otherwise normal growth and showed no
evidenceof immunedysregulation (FiguresS7C–S7G). Shp1-defi-
cient Treg cells, but not Shp1-sufficient Tconv cells, exhibited
enhanced amounts of phosphorylated STAT6 (pSTAT6) in
response to IL-4 (FigureS7F). Theyalsoexhibited increasedserum
IgE concentrations at baseline, indicative of Th2 cell skewing (Fig-
ure S7H). Foxp3EGFPCrePtpn6D/D mice orally sensitized with OVA-
SEBanaphylaxed uponoralOVAchallenge (Figure 7F). Compared
to control mice, they exhibited elevated total and OVA-specific
serum IgE concentrations and increased mast cell expansion in
the SI (Figures 7G–7I). Furthermore, Treg cells of OVA-SEB-sensi-
tized Foxp3EGFPCrePtpn6D/D mice exhibited higher expression of
IL-4, GATA-3, and IRF-4 than did those of control mice (Figures
S7I–S7M).These results indicate thatShp1deficiency inTregcells,
with its attendant enhanced IL-4R signaling, is sufficient to render
mice susceptible to food allergy.
DISCUSSION
Our results show that failure of Treg-cell-mediated oral tolerance
in the context of a Th2-cell-polarized gut environment is
Figure 6. Allergen-Specific Treg Cells of Food-Allergic Human Subjects Acquire a Th2-Cell-like Phenotype
(A and B) Flow cytometric analysis (A) and frequencies (B) of circulating CD4+CD25+Foxp3+ Treg cells in the peripheral blood of food-allergic children and age-
matched healthy control subjects. Cells were gated on live CD3+CD4+ cells and then analyzed for Foxp3 and CD25 expression.
(C and D) Flow cytometric analysis (C) and frequencies (D) of GATA-3+ and IRF-4+ Treg cells in food-allergic and control subjects.
(E and F) Flow cytometric analysis (E) and frequencies (F) of IL-4+ and IL-13+ allergen-specific Treg cells in milk-stimulated PBMC cultures from healthy control
subjects, food-allergic subjects, and milk-allergic subjects.
(G and H) Flow cytometric analysis (G) and frequencies (H) of IL-4- and IL-13-expressing CD4+Foxp3– Tconv cells in PBMC cultures of the respective groups
shown in (E) and (F).
Numbers in the flow plots represents means ± SEM of positive cells. n = 5–17 human subjects. *p < 0.05, **p < 0.01, and ***p < 0.001 by Student’s unpaired two-
tailed t test and one-way ANOVA with post-test analysis.fundamental to the pathogenesis of food allergy. By employing a
murine model that replicates key aspects of human food allergy,
including susceptibility to oral sensitization and response to oral
challenge with IgE-mediated anaphylaxis, we demonstrated that
formation of allergen-specific Treg cells decreased as a result of
enhanced IL-4R-STAT6 signaling. We also demonstrated that
allergen-specific Treg cells underwent Th2 cell reprogramming
driven by dysregulated IgE-FcεRIa signaling and mast cell
expansion. This reprogramming, which was also observed in hu-
man food-allergic subjects, was shown to be sufficient to impart
disease susceptibility. These findings outline a cascade ofcellular and molecular events that underlie the failure of Treg
cells to maintain oral tolerance in food allergy.
Impaired formation of food-allergen-specific Il4raF709 iTreg
cells, evident in both in vitro and in vivo models, reflected the in-
fluence of excessive IL-4R signaling and was corrected by Stat6
deletion. Il4raF709 allergen-specific iTreg cells proliferated less
and were more prone to apoptosis than their WT counterparts.
Their deficiency was compounded by ineffective disease-sup-
pressing function, which was completely corrected by blockade
of the STAT6 pathway, indicative of Treg cell subversion by
excessive IL-4R-STAT6 signaling. Consistent with this finding,Immunity 42, 512–523, March 17, 2015 ª2015 Elsevier Inc. 519
Figure 7. Lineage-Specific Upregulation of IL-4R Signaling in Treg Cells Confers Susceptibility to Food Allergy
(A) Flow cytometric analysis of MLN congenic Treg cells in Foxp3K276X mice rescued at birth with either WT or Il4raF709 Thy1.1+CD4+ T cells from Foxp3EGFP mice
and then sensitized with sham or OVA-SEB and challenged with OVA.
(B). Flow cytometric analysis of MLN cells of WT Foxp3 competent mice injected at birth with either WT or Il4raF709 Thy1.1+CD4+ T cells isolated from Foxp3EGFP
mice and then sensitized with sham or OVA-SEB and challenged with OVA.
(C) Changes in core body temperature in PBS- and OVA-SEB-sensitized rescued Foxp3K276X mice after OVA challenge.
(D) Total and OVA-specific serum IgE concentrations, SI mast cell count, and MMCP-1 release after anaphylaxis in PBS- and OVA-SEB-sensitized rescued
Foxp3K276X mice.
(E) Frequencies of IL-4-, IL-13-, IFN-g-, and IL-9-expressing CD4+Foxp3+ Treg cells in the MLNs of PBS- and OVA-SEB-sensitized Foxp3K276X rescued mice.
(F) Changes in core body temperature in Foxp3EGFPCre and Foxp3EGFPCrePtpn6D/D mice sensitized and challenged with OVA.
(G–I) Serum total and OVA-specific IgE concentrations (G), chloroacetate esterase staining of jejunal mast cells (revealed in red, H), and mast cell counts (I) of
OVA-SEB-sensitized Foxp3EGFPCre and Foxp3EGFPCrePtpn6D/D mice.
Results are representative of two independent experiments. n = 3–10 mice/group. *p < 0.05, **p < 0.01, and ***p < 0.001 by one- and two-way ANOVA with post-
test analysis and Student’s unpaired two-tailed t test.Treg cells of allergen-sensitized Il4raF709 mice exhibited intense
Th2-cell-like reprogramming, evidenced by higher expression
of GATA-3, IRF-4, and IL-4 in mutant Treg cells than in WT cells.
Previous studies have demonstrated that Treg cells appropriate
partial or ‘‘aborted’’ forms of the transcriptional programs of
target Th cells by expressing their master transcription factors,
such as T-bet for Th1 cells and IRF-4 for Th2 cells, and co-opting
their function (Koch et al., 2012; Zheng et al., 2009). GATA-3 in
particular plays a cardinal role in Treg cell homeostasis: it en-
ables their accumulation at sites of inflammation and prevents
their polarization into Th17 cells (Rudra et al., 2012; Wang
et al., 2011; Wohlfert et al., 2011). Whereas under physiological
conditions such partial Th cell programming remains restrained,
such restraint is lost under the influence of heightened STAT6520 Immunity 42, 512–523, March 17, 2015 ª2015 Elsevier Inc.signaling and thus leads to pathogenic reprogramming of Treg
cells into Th2-like cells. The production of IL-4 by the reprog-
rammed Treg cells directly contributes to disease, as evidenced
by its amelioration upon Treg-cell-lineage-specific deletion of Il4
and Il13. Aberrant reprogramming was also evident in allergen-
specific Treg cells of food-allergic children, indicating that it is
a pathogenic event common to experimental and human food
allergy.
The requisite role of enhanced IL-4R signaling in Treg cells in
disease pathogenesis was demonstrated in two experimental
models. First, engraftment of an Il4raF709 Treg cell lineage in
Foxp3-deficient mice transferred disease susceptibility. In the
second approach, Treg-cell-specific Shp1 deficiency, which
recapitulates the effects of the Il4raF709 ITIM mutation, was
sufficient to induce the reprogramming of Treg cells into Th2-like
cells and impart susceptibility to food allergy. These findings
indicate that Treg cells are a key locus of action of enhanced
IL-4R signaling in mediating susceptibility to food allergy.
The mechanism driving the acquisition by Treg cells of a Th2-
cell-like phenotype involved a dysregulated IgE-FcεRIa-mast-
cell axis. Mast cell expansion induced by allergen sensitization
of Il4raF709 mice was abrogated upon FcεRIa deficiency, and
both the conventional Th2 cell response and the reprogramming
of Treg cells into Th2-like cells were inhibited. Moreover, in vitro
suppression of mast cell activation by Il4raF709 Treg cells was
impaired in the presence of IL-4, a defect that was corrected
by STAT6 deletion. These findings outline a scenario in which
failure of Il4raF709 Treg cells to suppress mast cell activation
and expansion results in mast-cell-driven conventional Th2 cell
skewing and Treg cell reprogramming into Th2-like cells. Consis-
tent with thismodel is our recent demonstration that suppression
of mast cell activation and IL-4 production restores tolerance
and promotes Treg cell induction (Burton et al., 2014). Accord-
ingly, blockade of the IL-4-IL-4Ra pathway or depletion of IgE
and/or mast cells might augment allergen-specific iTreg cell
generation in food-allergic subjects and prevent their pathogenic
reprogramming, leading to lasting oral tolerance.
EXPERIMENTAL PROCEDURES
Animals
BALB/cByJ (WT) mice and all of the following strains, except where indicated,
were obtained from or re-derived at The Jackson Laboratory. C.129X1-
Il4ratm3.1Tch (Il4raF709), C.Cg-Foxp3tm2Tch/J (Foxp3EGFP), C.Cg-Foxp3tm1Tch
(Foxp3K276X), and the BALB/c congenics Thy1.1+Foxp3EGFP and DO11.10+
Foxp3EGFP have been previously described (Burton et al., 2014; Haribhai
et al., 2007; Mathias et al., 2011; Noval Rivas et al., 2013; Tachdjian
et al., 2010). NOD/ShiLt-Tg(Foxp3-EGFP/cre)1cJbs/J (Foxp3EGFPCre)
and B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J (R26YFP/YFP) mice were back-
crossed 12 generations on BALB/cBYJ (Zhou et al., 2008; Srinivas
et al., 2001). Foxp3EGFPCre mice were similarly backcrossed on C57BL/6J
(B6.Foxp3EGFPCre) mice. C.129S2-Fcer1atm1Knt (FcerIa–/–) and C.129P2(Cg)-
Il4-Il13tm1.1Lky (Il4-Il13fl/fl) mice, both BALB/c congenics, were crossed with
Il4raF709 and Il4raF709Foxp3EGFPCre mice as indicated (Dombrowicz et al.,
1993; Voehringer et al., 2009). C.129S2-Stat6tm1Gru (Stat6–/–) mice were
crossed with DO11.10+Foxp3EGFP and DO11.10+Il4raF709Foxp3EGFP mice (Ka-
plan et al., 1996). B6.129P2-Ptpn6tm1Rsky (Ptnp6fl/fl) mice were crossed with
B6.Foxp3EGFPCre mice (Pao et al., 2007). C.129S6(B6)-Rag2tm1Fwa (Rag2–/–)
(Shinkai et al., 1992) mice were obtained from Taconic and crossed with
DO11.10, Foxp3EGFP, or Il4raF709Foxp3EGFP mice (The Jackson Laboratory)
for generation of the respective transgenic mice. Mice were maintained under
specific pathogen-free conditions and used according to the guidelines of the
institutional animal research committee at Boston Children’s Hospital.
Sensitization and Challenge Protocol
Mice were treated intragastrically with either sterile PBS or OVA (250 mg,
Sigma-Aldrich) together with 10 mg SEB (Toxin Technology) in PBS (Treg cells)
once weekly for 8 weeks. In some experiments, mice were gavaged with SEB
(10 mg) alone. On week 9, mice were challenged intragastrically with 150 mg
OVA. Anaphylaxis was assessed by measurement of changes in total core
body temperature with transponders that were placed subcutaneously
2 days before challenge (IPTT-300, Bio Medic Data Systems) and a DAS-
6001 console (Bio Medic Data Systems).
TGF-b-Mediated In Vitro iTreg Cell Induction
Sorted naive CD4+CD62L+Foxp3EGFP– T cells (1 3 106/ml) were cultured with
plate-bound anti-CD28 (5 mg/ml, Biolegend), anti-CD3 (5 mg/ml, Biolegend),
recombinant TGF-b (5 ng/ml, R&D Systems), retinoic acid (10 nM, Sigma-Aldrich), and a gradient of recombinant IL-4 (Perpotech). After 3 days, the
induced iTreg cells were analyzed by flow cytometry and/or re-sorted on the
basis of EGFP fluorescence.
In Vivo iTreg Cell Conversion
For in vivo iTreg cell conversion experiments, naive CD4+DO11.10+Foxp3EGFP–
cells were isolated from WT or Il4raF709 DO11.10+Rag2–/–Foxp3EGFP mice by
magnetic-activated cell sorting (MACS) selection (purity > 95%). The cells
were labeled with Violet CellTrace Dye (Invitrogen) and adoptively transferred
(3 3 106) retro-orbitally into Il4raF709 mice that had been previously sensitized
withOAV-SEB for 8weeks. Themicewere then further sensitizedwithOVA-SEB
for 4 more weeks. After challenge with 150 mg OVA, the MLNs were collected
and analyzed by flow cytometry for the fluorescence of Violet CellTrace Dye,
DO11.10, and EGFP.
Treg Cell Adoptive Transfer
CD4+DO11.10+Foxp3EGFP iTreg cells were derived in vitro as detailed above.
For treatment of established disease, Il4raF709 recipients were sensitized
with OVA-SEB for 8 weeks. At week 9, the sensitized mice were retro-orbitally
given 53 106 WT or Il4raF709 CD4+DO11.10+Foxp3EGFP iTreg cells, sensitized
with OVA-SEB for 4 more weeks, and challenged at week 5 (150 mg of OVA).
For food-allergy prevention, CD4+DO11.10+Foxp3EGFP Treg cells were cell
sorted from WT and Il4raF709 DO11.10+Foxp3EGFP STAT6-sufficient or -defi-
cient mice. Il4raF709 mice were retro-orbitally given 0.53 106 of WT or Il4raF709
CD4+DO11.10+Foxp3EGFP Treg cells or in-vitro-derived iTreg cells on day 0 of
the sensitization protocol. The mice were then sensitized with OVA-SEB for
8 weeks and then challenged with OVA.
Human Study Population
Three groups of subjects, aged 6 months to 13 years, were recruited under a
protocol approved by the institutional review board at Boston Children’s Hos-
pital: (1) 12 healthy subjects without a history of food allergy, (2) eight subjects
with other food allergies (but no clinical history of milk allergy), and (3) eight
subjects with a milk allergy, as determined by the World Allergy Organization
diagnostic criteria (Fiocchi et al., 2010). Subject demographics and allergen
reactivity are detailed in Table S1, and inclusion and exclusion criteria are
detailed in the Supplemental Information.
Rescue of Foxp3K276X Mice
Splenic and lymph node CD4+ T cells were isolated fromWT Th1.1+Foxp3EGFP
and Thy1.1+Il4raF709Foxp3EGFPmice byMACS (Miltenyi Biotec). For the rescue
of Thy1.2+Foxp3K276X mice, 200 ml of purified 5 3 106 Thy1.1+CD4+ T cells
were injected into the peritoneal cavity of pups within the first 30 hr after birth.
Rescued Foxp3K276X/K276X females and Foxp3K276X males were maintained
and mated for the generation of litters in which all progeny were Foxp3
deficient.
Statistical Analysis
Anaphylaxis temperature curves were analyzed by two-way ANOVA. Stu-
dent’s unpaired two-tailed t tests were used for comparisons of two groups.
For more than two groups, one-way ANOVA with a Bonferroni post-test anal-
ysis was used. Results are presented as means (horizontal lines or rectangular
bars) and SEM, and each point represents one sample. Differences in mean
values were considered significant at a p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, one table, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2015.02.004.
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